Region Uppsala chooses to implement AI-based risk profiling with Stratipath Breast
3 June 2025
Region Uppsala, Sweden’s fourth largest healthcare region, has chosen to
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Region Uppsala, Sweden’s fourth largest healthcare region, has chosen to
Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic
Diagnexia has announced a partnership with Stratipath AB to bring
Diagnexia, and Stratipath AB are pleased to announce a strategic
Stratipath is proud to announce that globally recognized breast oncologist,
Stratipath has been recognized as one of the Gold Companies
Region Uppsala, Sweden’s fourth largest healthcare region, has chosen to
Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic
Diagnexia, and Stratipath AB are pleased to announce a strategic
Diagnexia has announced a partnership with Stratipath AB to bring
Stratipath has been recognized as one of the Gold Companies
SwAIPP 2, the continuation of the SwAIPP project, has been